Indefinite Delivery Contract W9114F26DA005
Award Date 1/1/26
Last Date to Order 12/31/30
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The Defense Health Agency awarded a single-award Indefinite Delivery Contract to Roche Diagnostics Corporation on October 1, 2023, with a ceiling value of $10,938,777.37 and an ultimate completion date of September 30, 2028. This contract procures chemistry and immunoassay testing supplies and services under a cost-per-reportable-result pricing model. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical...
- The Defense Health Agency has awarded a single-award Blanket Purchase Agreement to Roche Diagnostics Corporation (UEI: JDMDFEZBYH36) with a ceiling value of $606,000 for the provision of chemistry analyzer equipment and associated reagents on a cost-per-reportable-result basis. The contract, effective from October 1, 2025, through March 31, 2027, establishes a pricing mechanism that ties reimbursement directly to clinical testing output, enabling efficient procurement of diagnostic laboratory...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, received a single-award Indefinite Delivery Contract from the Defense Health Agency (DHA) on October 1, 2023, with a ceiling value of $7.42 million and an ultimate completion date of June 30, 2028. The contract procures chemistry reagents to support laboratory diagnostic operations across military and defense healthcare systems. The IDV does not utilize small business set-asides,...
- Roche Diagnostics Corporation was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency on October 1, 2021, for the supply of histology test reagents and Roche Diagnostics Ventana Medical System platform reagents. The indefinite delivery vehicle maintains a ceiling value of $1,774,824.38 and extends through September 30, 2026, with no set-aside designation. The contract was awarded on an open competitive basis and represents a firm-fixed-price arrangement under which...
- Roche Diagnostics Corporation was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency, with an ultimate completion date of September 30, 2028, and a ceiling value of approximately $6.0 million. The contract supports the supply of reagents, consumables, training, and maintenance services for a government-owned Roche Diagnostic Total Laboratory Automation system located at Madigan Army Medical Center. The contracted system comprises multiple Cobas Pro analytical...
- Roche Diagnostics Corporation has been awarded an indefinite delivery contract by the Department of the Army Medical Command to provide immunochemistry testing services. The single award contract has a potential value of $16.6M and period of performance through September 2023. Under the contract vehicle, Roche has received multiple delivery orders to conduct clinical chemistry and immunoassay testing at its facility in Castleton, Indiana for various Army medical treatment facilities. Orders have...
- Roche Diagnostics Corporation was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency with a ceiling value of $215,748.90, effective from October 1, 2025, through September 30, 2028. The contract, issued without set-aside designation, provides blood gas reagents, supplies, maintenance, and training services for Madigan Army Medical Center in Tacoma, Washington. This indefinite delivery vehicle serves as the parent contract mechanism enabling the government to issue...
- The Defense Health Agency (DHA) awarded a single-award Blanket Purchase Agreement to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments headquartered in Indianapolis, Indiana, for chemistry analyzers and chemistry lab testing supplies. The contract, valued at $9.0 million with an ultimate completion date of March 11, 2029, was awarded on March 12, 2024, without set-aside designation, reflecting open competition. The contract is...
- The federal contract IDV award is for an automated hematology analyzer and related reagents, consumables, controls, and maintenance services to support the hematology testing mission at the Vicenza Army Health Clinic in Italy. The contract was awarded by the Defense Health Agency, a defense agency responsible for providing healthcare services to U.S. military personnel and their families. The contract is structured as a single-award, indefinite delivery contract with a ceiling value of...
- This Indefinite Delivery Contract was awarded to Roche Diagnostics Corporation on October 1, 2025, by the Defense Health Agency with a ceiling value of $2.6 million and a performance period extending through April 30, 2031. The contract employs a single award structure with no set-asides and supports the procurement of Benchmark Ultra and Benchmark Special Stain products and services. As a child contract under the vendor's broader federal contracting portfolio, this IDV leverages Roche...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order W9114F26DA005-W9114F26FA027 | Roche Diagnostics S.P.A. | $3.4k | 1/2/26 | 2/28/26 | 12/29/25 |